Please login to the form below

Not currently logged in
Email:
Password:

Axovant poaches Allergan’s and Teva’s chief medical and science officers

Gavin Corcoran and Michael Hayden join the biopharma

Gavin and MichaelClinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development.

Corcoran’s career history has seen him supervise drug development across multiple therapeutic areas including neurology and psychiatry.

Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.

Throughout his career he has served in numerous roles for Celgene, Amgen, Schering-Plough and Bayer.

Corcoran said: “I look forward to working closely with the senior management team to bring new investigational medicines into the portfolio as we build upon Axovant’s capabilities in research and development.

“We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases.

“I am also eager to leverage the Roivant platform to accelerate the development of Axovant’s pipeline.”

Meanwhile, Teva’s former chief scientific officer Michael Hayden will also join Axovant, serving as its chairman of the scientific advisory board.

Prior to his time at Teva as its president of global research and development and chief scientific officer, Hayden founded multiple biotechnology companies including Aspreva Pharmaceuticals.

Pavan Cheruvu, chief executive officer, Axovant, said: “Since starting as CEO in February, I have been focused on transforming Axovant into a leaner organisation, introducing heightened standards of quality and excellence throughout the business, and establishing a new pipeline strategy.

“We are now poised for growth, and I am excited to have Gavin and Michael join us as we look toward expanding our pipeline in the coming months.”

5th June 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Infographics